Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Williams Buckley A, Hirtz D, Oskoui M, Armstrong MJ, Batra A, Bridgemohan C, Coury D, Dawson G, Donley D, Findling RL, Gaughan T, Gloss D, Gronseth G, Kessler R, Merillat S, Michelson D, Owens J, Pringsheim T, Sikich L, Stahmer A, Thurm A, Tuchman R, Warren Z, Wetherby A, Wiznitzer M, Ashwal S.

Neurology. 2020 Feb 12. pii: 10.1212/WNL.0000000000009033. doi: 10.1212/WNL.0000000000009033. [Epub ahead of print]

PMID:
32051244
2.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K.

Headache. 2019 Sep;59(8):1158-1173. doi: 10.1111/head.13628.

PMID:
31529481
3.

New Guidelines: Interpretation, Application and the Future.

Hershey AD, Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Licking N, Sowell M, Victorio MC, Gersz E, Vrijsen E, Zanitsch H, Yonker M, Mack K, Gelfand AA, Szperka CL, Powers SW.

Headache. 2019 Sep;59(8):1133-1143. doi: 10.1111/head.13629. No abstract available.

PMID:
31529478
4.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Cristina Victorio M, Yonker M, Zanitsch H, Hershey AD.

Headache. 2019 Sep;59(8):1144-1157. doi: 10.1111/head.13625.

PMID:
31529477
5.

Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Farez MF, Correale J, Armstrong MJ, Rae-Grant A, Gloss D, Donley D, Holler-Managan Y, Kachuck NJ, Jeffery D, Beilman M, Gronseth G, Michelson D, Lee E, Cox J, Getchius T, Sejvar J, Narayanaswami P.

Neurology. 2019 Sep 24;93(13):584-594. doi: 10.1212/WNL.0000000000008157. Epub 2019 Aug 28.

PMID:
31462584
6.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K.

Neurology. 2019 Sep 10;93(11):487-499. doi: 10.1212/WNL.0000000000008095. Epub 2019 Aug 14. Review. Erratum in: Neurology. 2020 Jan 7;94(1):50.

PMID:
31413171
7.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD.

Neurology. 2019 Sep 10;93(11):500-509. doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14. Review. Erratum in: Neurology. 2020 Jan 7;94(1):50.

PMID:
31413170
8.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):269-278. doi: 10.5698/1535-7597.18.4.269.

9.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):260-268. doi: 10.5698/1535-7597.18.4.260.

10.

Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.

PMID:
30126885
11.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Erratum in: Neurology. 2018 Dec 11;91(24):1117.

PMID:
29898974
12.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13.

PMID:
29898971
13.

Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.

Rayi A, Thompson S, Gloss D, Malhotra K.

Epilepsy Res. 2018 Jul;143:1-6. doi: 10.1016/j.eplepsyres.2018.03.022. Epub 2018 Mar 30.

PMID:
29625272
14.

Clinical utility of EEG in diagnosing and monitoring epilepsy in adults.

Tatum WO, Rubboli G, Kaplan PW, Mirsatari SM, Radhakrishnan K, Gloss D, Caboclo LO, Drislane FW, Koutroumanidis M, Schomer DL, Kasteleijn-Nolst Trenite D, Cook M, Beniczky S.

Clin Neurophysiol. 2018 May;129(5):1056-1082. doi: 10.1016/j.clinph.2018.01.019. Epub 2018 Feb 1. Review.

PMID:
29483017
15.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

17.

Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Fife TD, Colebatch JG, Kerber KA, Brantberg K, Strupp M, Lee H, Walker MF, Ashman E, Fletcher J, Callaghan B, Gloss DS 2nd.

Neurology. 2017 Nov 28;89(22):2288-2296. doi: 10.1212/WNL.0000000000004690. Epub 2017 Nov 1.

18.

The role of high-frequency oscillations in epilepsy surgery planning.

Gloss D, Nevitt SJ, Staba R.

Cochrane Database Syst Rev. 2017 Oct 5;10:CD010235. doi: 10.1002/14651858.CD010235.pub3. Review.

19.

Author response: Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Gloss D, Szaflarski JP, Holland SK, Binder JR, Theodore WH.

Neurology. 2017 Aug 8;89(6):640-641. doi: 10.1212/WNL.0000000000004203. No abstract available.

PMID:
28784637
20.

Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, French JA, Gil-Nagel A, Hesdorffer DC, Smithson WH, Spitz MC, Walczak TS, Sander JW, Ryvlin P.

Epilepsy Curr. 2017 May-Jun;17(3):180-187. doi: 10.5698/1535-7511.17.3.180.

21.

GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist.

Akl EA, Welch V, Pottie K, Eslava-Schmalbach J, Darzi A, Sola I, Katikireddi SV, Singh J, Murad MH, Meerpohl J, Stanev R, Lang E, Matovinovic E, Shea B, Agoritsas T, Alexander PE, Snellman A, Brignardello-Petersen R, Gloss D, Thabane L, Shi C, Stein AT, Sharaf R, Briel M, Guyatt G, Schünemann H, Tugwell P.

J Clin Epidemiol. 2017 Oct;90:68-75. doi: 10.1016/j.jclinepi.2017.01.017. Epub 2017 May 9.

22.

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, French JA, Gil-Nagel A, Hesdorffer DC, Smithson WH, Spitz MC, Walczak TS, Sander JW, Ryvlin P.

Neurology. 2017 Apr 25;88(17):1674-1680. doi: 10.1212/WNL.0000000000003685. Erratum in: Neurology. 2019 Nov 26;93(22):982. Neurology. 2020 Feb 7;:.

PMID:
28438841
23.

Cannabinoids in treatment-resistant epilepsy: A review.

O'Connell BK, Gloss D, Devinsky O.

Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Review.

PMID:
28188044
24.

Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Szaflarski JP, Gloss D, Binder JR, Gaillard WD, Golby AJ, Holland SK, Ojemann J, Spencer DC, Swanson SJ, French JA, Theodore WH.

Neurology. 2017 Jan 24;88(4):395-402. doi: 10.1212/WNL.0000000000003532. Epub 2017 Jan 11.

25.

Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T.

Neurology. 2016 Dec 13;87(24):2585-2593. Epub 2016 Nov 16.

27.

Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

Topaloglu H, Gloss D, Moxley RT 3rd, Ashwal S, Oskoui M.

Neurology. 2016 Jul 12;87(2):238. doi: 10.1212/01.wnl.0000489553.99227.18. No abstract available.

PMID:
27402942
28.

Utilizing bi-spectral index (BIS) for the monitoring of sedated adult ICU patients: a systematic review.

Bilgili B, Montoya JC, Layon AJ, Berger AL, Kirchner HL, Gupta LK, Gloss DS.

Minerva Anestesiol. 2017 Mar;83(3):288 - 301. doi: 10.23736/S0375-9393.16.10886-7. Epub 2016 Jun 17.

29.

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA.

Neurology. 2016 May 10;86(19):1818-26. doi: 10.1212/WNL.0000000000002560. Epub 2016 Apr 18.

30.

Guideline authors' response to Dr Saper's idiopathic normal pressure hydrocephalus commentary.

Halperin JJ, Gronseth G, Gloss D.

Ann Neurol. 2016 May;79(5):865. doi: 10.1002/ana.24644. Epub 2016 Apr 9. No abstract available.

PMID:
27004459
31.

Managing an Unprovoked First Seizure in Adults.

Gloss DS, Krumholz A.

CNS Drugs. 2016 Mar;30(3):179-83. doi: 10.1007/s40263-016-0321-z. Review. No abstract available.

PMID:
26914913
32.

Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, Bare M, Bleck T, Dodson WE, Garrity L, Jagoda A, Lowenstein D, Pellock J, Riviello J, Sloan E, Treiman DM.

Epilepsy Curr. 2016 Jan-Feb;16(1):48-61. doi: 10.5698/1535-7597-16.1.48.

33.
34.

Author Response.

Krumholz A, Shinnar S, French J, Wiebe S, Gloss D.

Neurology. 2015 Oct 27;85(17):15255-6. No abstract available.

PMID:
26811855
35.

Photocatalytic Properties of TiO2 Thin Films Modified with Ag and Pt Nanoparticles Deposited by Gas Flow Sputtering.

Maicu M, Glöss D, Frach P, Hecker D, Gerlach G, Córdoba JM.

J Nanosci Nanotechnol. 2015 Sep;15(9):6478-86.

PMID:
26716202
36.
37.

Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA.

Epilepsy Curr. 2015 May-Jun;15(3):144-52. doi: 10.5698/1535-7597-15.3.144. No abstract available.

38.

Medical marijuana: Between a plant and a hard place.

Gloss DS, Maa EH.

Neurol Clin Pract. 2015 Aug;5(4):281-284. doi: 10.1212/CPJ.0000000000000159. No abstract available.

39.

An Overview of Products and Bias in Research.

Gloss D.

Neurotherapeutics. 2015 Oct;12(4):731-4. doi: 10.1007/s13311-015-0370-x. Review.

40.

Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA.

Neurology. 2015 Apr 21;84(16):1705-13. doi: 10.1212/WNL.0000000000001487.

41.

Quality improvement in neurology: Epilepsy Update Quality Measurement Set.

Fountain NB, Van Ness PC, Bennett A, Absher J, Patel AD, Sheth KN, Gloss DS, Morita DA, Stecker M.

Neurology. 2015 Apr 7;84(14):1483-7. doi: 10.1212/WNL.0000000000001448. No abstract available.

42.

Radiology of the month. Headache. Subdural hematoma.

Gloss DS, Varma J, Lehnhoff L, Neitzschman H.

J La State Med Soc. 2013 Nov-Dec;165(6):345-6.

PMID:
25073263
43.

Interventional neuroradiology cases with intraprocedural clots: initial experience.

Gloss DS, Alkire BW.

J Clin Neurophysiol. 2014 Jun;31(3):229-31. doi: 10.1097/WNP.0000000000000046.

PMID:
24887605
44.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D.

Neurology. 2014 Apr 29;82(17):1556-63. doi: 10.1212/WNL.0000000000000363. Review.

45.

Cannabinoids for epilepsy.

Gloss D, Vickrey B.

Cochrane Database Syst Rev. 2014 Mar 5;(3):CD009270. doi: 10.1002/14651858.CD009270.pub3. Review.

PMID:
24595491
46.

The role of high-frequency oscillations in epilepsy surgery planning.

Gloss D, Nolan SJ, Staba R.

Cochrane Database Syst Rev. 2014 Jan 15;(1):CD010235. doi: 10.1002/14651858.CD010235.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Oct 05;10 :CD010235.

47.

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the american academy of neurology.

Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C.

Epilepsy Curr. 2013 Nov;13(6):297-303. doi: 10.5698/1535-7597-13.6.297.

48.

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C.

Neurology. 2013 Oct 15;81(16):1453-9. doi: 10.1212/WNL.0b013e3182a393d1. Epub 2013 Aug 28. Review.

49.

Epileptogenesis in the developing brain.

Wasterlain CG, Gloss DS, Niquet J, Wasterlain AS.

Handb Clin Neurol. 2013;111:427-39. doi: 10.1016/B978-0-444-52891-9.00046-4. Review.

PMID:
23622191
50.

Cannabinoids for epilepsy.

Gloss D, Vickrey B.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD009270. doi: 10.1002/14651858.CD009270.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(3):CD009270.

PMID:
22696383

Supplemental Content

Support Center